PapersFlow Research Brief
Infectious Diseases and Tuberculosis
Research Guide
What is Infectious Diseases and Tuberculosis?
Infectious Diseases and Tuberculosis refers to a cluster of research on the diagnosis, treatment, and immune mechanisms of tuberculosis and related infections, including spinal epidural abscess, tuberculous meningitis, vertebral osteomyelitis, nontuberculous mycobacterial diseases, and immune reconstitution inflammatory syndrome in HIV patients on antiretroviral therapy.
This field encompasses 75,627 published works focused on clinical presentation, management, outcomes, risk factors, and meta-analyses of spinal infections and tuberculosis. Key areas include diagnostic imaging, surgical management, and clinical practice guidelines for conditions like prosthetic joint infection and nontuberculous mycobacterial lung disease. Growth rate over the past 5 years is not available.
Topic Hierarchy
Research Sub-Topics
Spinal Epidural Abscess Management
This sub-topic covers clinical presentation, diagnostic imaging, and surgical drainage of spinal epidural abscesses. Researchers analyze risk factors, outcomes, and antibiotic protocols.
Tuberculous Meningitis
This sub-topic examines clinical features, CSF analysis, and antitubercular therapy for tuberculous meningitis. Researchers study adjunctive corticosteroids and prognostic biomarkers.
Vertebral Osteomyelitis
This sub-topic investigates pyogenic and tuberculous vertebral osteomyelitis diagnosis and conservative vs. surgical management. Researchers perform meta-analyses on long-term outcomes and recurrence.
Immune Reconstitution Inflammatory Syndrome
This sub-topic studies IRIS manifestations in HIV patients starting antiretroviral therapy, particularly TB-IRIS. Researchers evaluate risk factors, timing, and corticosteroid treatment efficacy.
Nontuberculous Mycobacterial Infections
This sub-topic covers diagnosis, antimicrobial susceptibility, and treatment guidelines for NTM pulmonary and extrapulmonary disease. Researchers address emerging resistance patterns.
Why It Matters
Research in this field guides clinical decisions for high-risk infections, such as screening for latent tuberculosis before initiating infliximab therapy, where Keane et al. (2001) reported active tuberculosis developing soon after treatment start in susceptible patients. Guidelines like "Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of America" (Osmon et al., 2012) provide evidence-based recommendations used by infectious disease specialists and orthopedists, aiding in the management of prosthetic joint infections that affect joint function and healthcare systems. Flynn et al. (1993) demonstrated interferon gamma's essential role in resisting Mycobacterium tuberculosis, informing immunotherapy strategies, while Jeon and Murray (2008) showed diabetes mellitus doubles the risk of active tuberculosis across 13 observational studies, targeting diabetic patients for TB control interventions.
Reading Guide
Where to Start
"An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases" (Griffith et al., 2007) provides foundational diagnostic criteria, laboratory features, and treatment guidelines with 5947 citations, serving as an accessible entry for clinical applications.
Key Papers Explained
"An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection" (Flynn et al., 1993, 2449 citations) establishes interferon gamma's protective mechanism, extended by "Disseminated tuberculosis in interferon gamma gene-disrupted mice" (Cooper et al., 1993, 1993 citations) showing macrophage activation roles and "Tumor necrosis factor-α is required in the protective immune response against mycobacterium tuberculosis in mice" (Flynn et al., 1995, 1676 citations) linking TNF-α to immunity. "Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent" (Keane et al., 2001, 3673 citations) applies these to clinical risks from TNF inhibitors. "Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of America" (Osmon et al., 2012, 2159 citations) builds on infection management principles for orthopedic contexts.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Current research emphasizes meta-analyses on risk factors for spinal infections like vertebral osteomyelitis and clinical practice guidelines for surgical management, though no recent preprints or news from the last 12 months are available.
Papers at a Glance
Frequently Asked Questions
What are the diagnostic criteria for nontuberculous mycobacterial lung disease?
Diagnostic criteria include clinical, radiographic, and microbiologic features as outlined in "An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases" (Griffith et al., 2007). Key laboratory features distinguish NTM from other pathogens. These criteria support prophylaxis and treatment decisions.
How does infliximab increase tuberculosis risk?
Infliximab, a tumor necrosis factor α–neutralizing agent, is associated with active tuberculosis developing soon after treatment initiation, as shown in "Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent" (Keane et al., 2001). Physicians must screen patients for latent tuberculosis infection beforehand. This applies to immunocompromised individuals.
What is the role of interferon gamma in tuberculosis resistance?
Interferon gamma plays an essential role in resistance to Mycobacterium tuberculosis infection, as mice lacking this cytokine showed increased susceptibility in "An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection" (Flynn et al., 1993). T cell-mediated immunity activates macrophages against the pathogen. This underscores its importance in protective responses.
What do guidelines recommend for prosthetic joint infection?
The "Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of America" (Osmon et al., 2012) offers evidence-based and opinion-based recommendations for diagnosis and management. These target infectious disease specialists, orthopedists, and healthcare professionals. Proper application preserves joint function.
How does diabetes affect tuberculosis risk?
Diabetes mellitus increases the risk of active tuberculosis, confirmed in a systematic review of 13 observational studies in "Diabetes Mellitus Increases the Risk of Active Tuberculosis: A Systematic Review of 13 Observational Studies" (Jeon and Murray, 2008). The association holds across study designs and populations. Diabetic patients benefit from active TB case finding.
Open Research Questions
- ? How can diagnostic imaging improve early detection of spinal epidural abscess and tuberculous meningitis?
- ? What are the long-term outcomes of surgical management for vertebral osteomyelitis?
- ? How does immune reconstitution inflammatory syndrome manifest in HIV patients on antiretroviral therapy during tuberculosis treatment?
- ? Which host immune defects beyond interferon gamma contribute to nontuberculous mycobacterial disease susceptibility?
- ? What risk factors predict prosthetic joint infection recurrence after treatment?
Recent Trends
The field maintains 75,627 works with no specified 5-year growth rate; highly cited papers from 1993-2014, such as Griffith et al. with 5947 citations on nontuberculous mycobacterial diseases and Keane et al. (2001) with 3673 citations on infliximab-TB risks, continue to shape guidelines.
2007No recent preprints or news coverage in the last 12 months indicates steady reliance on established studies.
Research Infectious Diseases and Tuberculosis with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Infectious Diseases and Tuberculosis with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers